Y. Rousselin, N. Sok, F. Boschetti, R. Guilard, F. Denat
45.2, 45.6, 46.1, 46.4, 48.6, 50.1, 50.5, 51.3, 51.4, 52.3, 55.7 (CH2- 46.8, 48.3, 48.6, 50.0, 50.2, 52.2, 52.7, 52.9, 55.5, 66.2 (CH2-α),
FULL PAPER
α), 60.5, 63.3 (CH), 77.3, 78.4, 79.4, 80.3 (N-C-N) ppm. MS
77.9, 81.5 (CH-aminal), 123.2, 124.5, 124.6, 124.8 (ϫ2), 125.2,
125.3 (ϫ2), 125.4 (ϫ2), 125.6, 126.2, 126.8 (ϫ2), 128.3, 128.7, 128.9
(ϫ2), 129.0, 129.3, 129.4, 129.6, 129.7, 130.0, 130.5, 130.7, 131.5,
132.2 (Car) ppm. ESI: m/z = 390.26 [M+ + H]. C24H31N5 (389.54):
calcd. C 74.00, H 8.02, N 17.98; found C 73.61, H 8.80, N 18.26.
(MALDI-TOF): m/z = 251.32 [M]+.
cis-(9b,9c-Dimethyldecahydro-2a,4a,7a,9a-tetraazacyclopenta[cd]-
phenylen-1-yl)methanamine (6): A solution of 4 (40.73 g, 0.156 mol)
in dry THF (50 mL) was slowly added to a suspension of LiAlH4
(11.8 g, 0.31 mol, 2 equiv.) in THF (200 mL) under nitrogen at 15-Phenyl-1,4,8,11,14-pentaazabicyclo[10.3.1]hexadecane (10):
–78 °C. The resulting mixture was stirred overnight. Ethyl acetate
(100 mL) and then water (25 mL) were carefully added. After re-
moval of the solvent, the residual white-grey solid was taken up in
Benzaldehyde (0.3 mL, 3.5 mmol) was added at 0 °C to a solution
of 8 (0.76 g, 3.5 mmol) in ethanol (50 mL). The mixture was stirred
at this temperature for 5 h. The solvent was evaporated and the
chloroform (2ϫ200 mL) and insoluble products were eliminated residual oil was taken up in pentane (50 mL). The insoluble impuri-
by filtration. Compound 6 was obtained as a colorless oil (yield
32.16 g, 78 %) as two diastereoisomers. 1H NMR (300 MHz,
CDCl3, 300 K): δ = 1.04 (s, 3 H), 1.12 (s, 3 H), 1.27 (s, 2.9 H), 1.28
ties were removed by filtration. Compound 10 was obtained as col-
orless crystals upon slow evaporation of the solvent; m.p.
93.8(5) °C; yield 0.74 g, 2.4 mmol, 70%. Two diastereoisomers were
1
(s, 2.9 H), 1.76 (m, 1.3 H), 2.2–3.6 (m, 26.6 H) ppm. 13C{1H} NMR obtained. H NMR (300 MHz, CDCl3, 300 K): δ = 1.43–3.30 (m,
(75 MHz, CDCl3, 300 K): δ = 11.9, 12.3 (ϫ2), 13.4 (CH3), 18.7, 46 H), 3.96 (s, 1 H), 4.37 (s, 1 H), 7.26–7.56 (m, 10 H) ppm.
25.8 (CH2-β), 44.8, 44.9, 45.7, 45.9, 46.5, 46.6, 47.2 (ϫ2), 48.0,
48.3, 48.4, 49.4, 50.0, 50.1, 51.0, 51.1 (CH2-α), 61.8, 68.1 (C-H), 51.0 (ϫ2), 51.7, 51.8, 53.0, 53.1, 53.7, 54.6, 54.7, 54.9, 55.5, 55.6,
13C{1H} NMR (75 MHz, CDCl3, 300 K): δ = 32.0, 32.5 (CH2-β),
73.2, 73.4, 79.3, 80.5 (N-C-N) ppm. MS (MALDI-TOF): m/z =
56.1, 56.5, 57.1, 57.2 (CH2-α), 67.9 (ϫ2) (CH), 85.8, 90.0 (N-C-N),
131.0 (ϫ3), 131.8, 132.1, 132.2 (ϫ3), 132.5 (ϫ2) (CHar), 145.0,
145.4 (Car) ppm. MS (MALDI-TOF): m/z = 304.09 [M + H]+.
C17H29N5 (303.45): calcd. C 67.09, H 9.63, N 23.08; found C 67.31,
H 9.66, N 22.40.
265.82 [M]+.
(1,4,7,10-Tetraazacyclododecan-2-yl)methanamine (7): A solution of
35% hydrochloric acid (40 mL, 0.4 mol, 7 equiv.) was slowly added
to compound 5 (15.0 g, 0.06 mol). The mixture was heated at reflux
overnight. After cooling at room temperature, a precipitate was
formed. The light-brown solid was filtered and washed successively
with ethanol and with diethyl ether. A white powder was obtained.
Then the solid was taken up in a 16 NaOH solution (20 mL) and
extracted with chloroform. Compound 7 was obtained as a yellow
oil (yield 4.3 g, 0.02 mol, 39 %). 1H NMR (300 MHz, CDCl3,
15-(Pyridin-2-yl)-1,4,8,11,14-pentaazabicyclo[10.3.1]hexadecane
(11): 2-Pyridinecarbaldehyde (0.22 g, 2 mmol) was added at 0 °C to
a solution of 8 (0.44 g, 2 mmol) in ethanol (50 mL). The mixture
was stirred at this temperature overnight. The solvent was evapo-
rated, and the residual oil was taken up in pentane (50 mL). The
insoluble impurities were removed by filtration. After evaporation
300 K): δ = 1.75 (s, 6 H), 2.49–2.66 (m, 17 H) ppm. 13C{1H} NMR of the solvent, compound 11 was obtained as a colorless oil; yield
(75 MHz, CDCl3, 300 K): δ = 44.1, 44.6, 46.0, 46.3, 46.4, 46.7,
46.8, 48.9 (CH2-α), 57.2 (CH) ppm. MS (MALDI-TOF): m/z =
201.75 [M]+.
0.45 g, 1.5 mmol, 74%. Two diastereoisomers were obtained. 1H
NMR (300 MHz, CDCl3, 300 K): δ = 1.15–3.19 (m, 46 H), 4.06 (s,
1 H), 4.41 (s, 1 H), 7.15 (m, 2 H), 7.36 (m, 2 H), 7.51 (m, 2 H),
8.49 (m, 2 H) ppm. 13C{1H} NMR (75 MHz, CDCl3, 300 K): δ =
28.2, 28.8 (CH2-β), 47.1, 47.2, 48.0, 49.2 (ϫ2), 49.5, 50.6, 50.8,
51.1, 51.6, 51.7, 51.8, 52.3, 52.6, 53.5, 53.6 (CH2-α), 64.5 (ϫ2)
(CH), 82.8, 86.2 (N-C-N), 122.1, 122.2, 123.2, 123.3, 136.6, 137.0,
149.4, 149.5 (CHar), 160.0, 160.7 (Car) ppm.
(1,4,7,10-Tetraazacyclotridecan-5-yl)methanamine (8): A solution of
35% hydrochloric acid (107 mL, 1.2 mol, 10 equiv.) was added to a
solution of 6 (32.16 g, 0.12 mol) in ethanol (200 mL). The resulting
mixture was heated at reflux for 4 h. After cooling, the solution was
filtered and washed with ethanol (50 mL) and then diethyl ether
(100 mL). The solid was dissolved in a saturated 15 NaOH solu-
tion (10 mL). After extraction with chloroform (2ϫ150 mL), the
organic phase was dried with MgSO4 and the solvent was evapo-
rated. Compound 8 was obtained as a white solid; m.p. 78.8(5) °C;
yield 11.02 g, 42%. Single crystals of 8 were obtained by slow evap-
N-[(1,4,7,10-Tetraazacyclododecan-2-yl)methyl]-1-(anthracen-9-yl)-
methanamine (12): NaBH4 (0.15 g, 3.84 mmol) was added to a solu-
tion of 9 (0.3 g, 0.77 mmol) in ethanol (10 mL) at room tempera-
ture. The mixture was stirred at room temperature for 12 h. The
solvent was then removed and the residual orange oil was taken up
in diethyl ether (20 mL). The insoluble salts were removed by fil-
1
oration of pentane. H NMR (300 MHz, CDCl3, 300 K): δ = 1.63
(m, 2 H), 1.87 (s, 6 H), 2.67–2.76 (m, 17 H) ppm. 13C{1H} NMR tration through CLARCEL®. After evaporation of the solvent
(75 MHz, CDCl3, 300 K): δ = 28.9 (CH2-β), 44.3, 46.2, 47.7, 49.0, compound 12 was obtained as a yellow oil; yield 0.20 g, 0.51 mmol,
49.0, 49.7, 49.8, 50.8 (CH2-α), 59.0 (CH) ppm. MS (MALDI-
67%. 1H NMR (500 MHz, CDCl3, 300 K): δ = 1.89 (br. s, 4 H),
TOF): m/z = 215.68 [M]+. C10H25N5·0.2H2O (221.62): calcd. C 2.25–2.73 (m, 18 H), 4.50 (m, 2 H), 7.31 (m, 4 H), 7.80 (m, 2 H),
54.86, H 11.69, N 31.99; found C 55, H 11.57, N 31.81.
8.19 (m, 3 H) ppm. 13C{1H} NMR (125 MHz, CDCl3, 300 K): δ =
44.3, 45.9 (ϫ2), 46.0, 46.3, 46.8, 47.0, 49.0, 52.7 (CH2-α), 55.1
(CH), 124.3, 124.9, 126.0, 127.0, 129.0, 130.3, 131.5, 131.9
(Car) ppm.
14-(Anthracen-9-yl)-1,4,7,10,13-pentaazabicyclo[9.3.1]pentadecane
(9): Anthracene-9-carbaldehyde (0.25 g, 1.25 mmol) was added to
a solution of 7 (0.25 g, 1.25 mmol) in ethanol (20 mL) at room
temperature. The mixture was stirred at room temperature for 12 h.
Then the solvent was removed and the residual oil was taken up in
diethyl ether (50 mL). The insoluble salts were removed by fil-
tration and after 12 h crystals appeared. After filtration, compound
9 was obtained as yellow needles; m.p. 153.4(5) °C; yield 0.3 g,
0.5 mmol, 61%. 1H NMR (600 MHz, CDCl3, 300 K): δ = 2.08–
3.06 (m, 36 H), 3.14–3.25 (m, 4 H), 3.53 (m, 1 H), 3.84–4.08 (m, 2
N-[(1,4,7,10-Tetraazacyclotridecan-5-yl)methyl]-1-phenylmethan-
amine (13): NaBH4 (0.11 g, 3 mmol, 10 equiv.) was added at 0 °C
to a solution of 10 (90 mg, 297 µmol) in ethanol (25 mL). The mix-
ture was heated at reflux overnight. The solvent was evaporated
and the residual solid was taken up in chloroform (50 mL). After
filtration and evaporation of the solvent, the residual oil was taken
up in pentane (30 mL). The insoluble impurities were removed by
H), 5.64–5.86 (m, 1 H), 7.40–7.51 (m, 8 H), 7.92–8.08 (m, 4 H), filtration. After evaporation of the solvent, compound 13 was ob-
8.47 (m, 4 H), 9.43 (m, 2 H) ppm. 13C{1H} NMR (150 MHz,
CDCl3, 300 K): δ = 43.3, 44.9, 45.2, 46.0, 46.2, 46.6, 46.7, 46.7,
tained as a colorless oil; yield 90 mg, 297 µmol, 98%. 1H NMR
(300 MHz, CDCl3, 300 K): δ = 1.60 (m, 2 H), 2.19 (s, 5 H), 2.44–
1692
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 1688–1693